Christine Dela Cruz

Bristol-Myers Squibb (United States)

1

h-index

1

Publications

4,168

Citations

Publications

1 shown

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Anthony B. El-Khoueiry , Bruno Sangro , Thomas Yau +18 more

2017 The Lancet 4168 citations

Frequent Co-Authors

Anthony B. El-Khoueiry

USC Norris Comprehensive Cancer Center

Bruno Sangro

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Thomas Yau

University of Hong Kong

Todd S. Crocenzi

Providence Health & Services

Masatoshi Kudo

Kindai University

Chiun Hsu

National Taiwan University Hospital

Researcher Info

h-index: 1
Publications: 1
Citations: 4,168
Institution: Bristol-Myers Squibb (United States)

External Links

Google Scholar

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.